Bionovo, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Monday, August 10, 2009
EMERYVILLE, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Bionovo, Inc.
(Nasdaq: BNVI) announced today that it will release financial results for the
second quarter of fiscal year 2009 ended June 30, 2009 on Monday, August 10,
2009. The Company will conduct a conference call and web cast to review the
financial results on Monday, August 10, 2009 at 5:00 p.m. ET.
Interested parties can access the call by dialing (800) 860-2442 or (412)
858-4600, or can listen via a live Internet web cast, which can be found at
http://bionovo.com/investors/events. A replay of the call is available via web
cast at http://bionovo.com/investors/events for 30 days or by playback at
(877) 344-7549 or (412) 317-0088, conference code 432836, through August 13,
About Bionovo, Inc.
Bionovo, Inc. is a pharmaceutical company focused on the discovery and
development of safe and effective treatments for women's health and cancer,
markets with significant unmet needs and billions in potential annual revenue.
The company applies its expertise in the biology of menopause and cancer to
design new drugs derived from botanical sources which have novel mechanisms of
action. Based on the results of early and mid-stage clinical trials, Bionovo
believes they have discovered new classes of drug candidates within their rich
pipeline with the potential to be leaders in their markets. Bionovo is
headquartered in Emeryville, California and is traded on the NASDAQ Capital
Market under the symbol, "BNVI". For more information about Bionovo and its
programs, visit: http://www.bionovo.com. BNVI-F
SOURCE Bionovo, Inc.
/CONTACT: Claire Fong, or Tom Chesterman, both of Bionovo, Inc.,
+1-510-601-2000, firstname.lastname@example.org; or Joe Diaz, Robert Blum, or Joe
Dorame, All of Lytham Partners, LLC, +1-602-889-9700, BNVI@lythampartners.com,
For Bionovo, Inc./
/Web Site: http://www.bionovo.com /
CO: Bionovo, Inc.
IN: HEA MTC PHA BIO
-- SF55760 --
7360 08/03/2009 16:15 EDT http://www.prnewswire.com